CN1340302A - 核酸补充营养保健食品及其制作方法 - Google Patents
核酸补充营养保健食品及其制作方法 Download PDFInfo
- Publication number
- CN1340302A CN1340302A CN00122867A CN00122867A CN1340302A CN 1340302 A CN1340302 A CN 1340302A CN 00122867 A CN00122867 A CN 00122867A CN 00122867 A CN00122867 A CN 00122867A CN 1340302 A CN1340302 A CN 1340302A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- health
- ethanol
- care food
- supplementing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 55
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 54
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 54
- 235000013305 food Nutrition 0.000 title claims abstract description 26
- 230000000050 nutritive effect Effects 0.000 title claims abstract description 22
- 230000001502 supplementing effect Effects 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims description 8
- 230000008569 process Effects 0.000 title claims description 3
- 102000007327 Protamines Human genes 0.000 claims abstract description 13
- 108010007568 Protamines Proteins 0.000 claims abstract description 13
- 229940048914 protamine Drugs 0.000 claims abstract description 13
- 235000013343 vitamin Nutrition 0.000 claims abstract description 8
- 239000011573 trace mineral Substances 0.000 claims abstract description 5
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 241000251468 Actinopterygii Species 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 150000003722 vitamin derivatives Chemical group 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 238000007670 refining Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000007602 hot air drying Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 claims description 2
- 238000009736 wetting Methods 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 claims description 2
- 239000003223 protective agent Substances 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000029087 digestion Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 14
- 229930003270 Vitamin B Natural products 0.000 description 10
- 235000019156 vitamin B Nutrition 0.000 description 10
- 239000011720 vitamin B Substances 0.000 description 10
- 235000013402 health food Nutrition 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 206010039966 Senile dementia Diseases 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 235000019688 fish Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000002035 prolonged effect Effects 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000251730 Chondrichthyes Species 0.000 description 3
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000000845 cartilage Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000006386 memory function Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241001125048 Sardina Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000019512 sardine Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000004987 nonapoptotic effect Effects 0.000 description 1
- 238000001216 nucleic acid method Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001228676A CN1209978C (zh) | 2000-08-30 | 2000-08-30 | 核酸补充营养保健食品及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001228676A CN1209978C (zh) | 2000-08-30 | 2000-08-30 | 核酸补充营养保健食品及其制作方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1340302A true CN1340302A (zh) | 2002-03-20 |
CN1209978C CN1209978C (zh) | 2005-07-13 |
Family
ID=4589373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001228676A Expired - Fee Related CN1209978C (zh) | 2000-08-30 | 2000-08-30 | 核酸补充营养保健食品及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1209978C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102573885A (zh) * | 2009-10-02 | 2012-07-11 | 最终未来国际股份有限公司 | 具有脂肪分解促进作用的组合物 |
CN102892423A (zh) * | 2010-05-21 | 2013-01-23 | 最终未来国际股份有限公司 | 促进脂联素产生的组合物 |
CN115737820A (zh) * | 2022-11-15 | 2023-03-07 | 河北医科大学第二医院 | 一种改善癫痫后认知损害的药物 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110551747A (zh) * | 2019-09-09 | 2019-12-10 | 河北医科大学 | 一种延缓皮肤衰老基因工程核酸因子膏的制备方法及使用方法 |
-
2000
- 2000-08-30 CN CNB001228676A patent/CN1209978C/zh not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102573885A (zh) * | 2009-10-02 | 2012-07-11 | 最终未来国际股份有限公司 | 具有脂肪分解促进作用的组合物 |
CN102573885B (zh) * | 2009-10-02 | 2014-12-17 | 最终未来国际股份有限公司 | 具有脂肪分解促进作用的组合物 |
US9399043B2 (en) | 2009-10-02 | 2016-07-26 | Final Future International, Inc. | Composition having lipolysis-promoting effect |
CN102892423A (zh) * | 2010-05-21 | 2013-01-23 | 最终未来国际股份有限公司 | 促进脂联素产生的组合物 |
CN102892423B (zh) * | 2010-05-21 | 2014-12-03 | 最终未来国际股份有限公司 | 促进脂联素产生的组合物 |
CN115737820A (zh) * | 2022-11-15 | 2023-03-07 | 河北医科大学第二医院 | 一种改善癫痫后认知损害的药物 |
Also Published As
Publication number | Publication date |
---|---|
CN1209978C (zh) | 2005-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2616523T3 (es) | Recuperación de proteínas | |
CN108835262B (zh) | 一种改善记忆力的调制乳粉及其制备方法 | |
AU2020102055A4 (en) | Brain-building gel candy and preparation method thereof | |
CN106805221A (zh) | 减肥用营养干预代餐营养棒 | |
CN102614499B (zh) | 一种具有抗疲劳功效的牦牛皮胶复方藏药及其制备工艺 | |
CN105747235B (zh) | 一种能改善代谢综合征症状的饮食组合物 | |
CN103005466B (zh) | 一种雄蜂蛹多肽提取物的应用 | |
CN1860902A (zh) | 补充人体营养元素的无糖型螺旋藻硬糖和软糖及制备方法 | |
CN108703364A (zh) | 脂肪酸代谢异常专用型临床营养配方及其制备方法 | |
CN103975991B (zh) | 桑果花青素保健饼干 | |
CN109170086A (zh) | 一种具有免疫增强功能的蛋白核小球藻压片糖果及其制备方法 | |
CN109730309A (zh) | 健脑益智安神缓解压力益智仁复合多肽营养素及制备方法 | |
CN102429126A (zh) | 含有酵母酶解物的乳仔猪饲料 | |
CN105795301A (zh) | 一种具有排毒降脂作用的固体饮料及其制备方法 | |
HaÅ et al. | The effect of addition bee pollen to feed mixtures on internal fat of broiler Ross 308 | |
CN1340302A (zh) | 核酸补充营养保健食品及其制作方法 | |
CN106418067A (zh) | 一种补充体力、缓解疲劳的保健饮料 | |
CN101999671A (zh) | 蚕蛹蛋白的应用 | |
CN1313102C (zh) | 一种甲鱼保健胶囊及其制备方法 | |
JP2003304845A (ja) | 飲料または食品 | |
CN102174628B (zh) | 一种花生生物活性肽的制备方法 | |
CN1763091A (zh) | 蛹蛋白及其生产工艺 | |
CN1582964A (zh) | 一种羊胎保健品及其制备方法 | |
CN1286503C (zh) | 一种具有降低血糖、血脂作用的中药组合物及其制备方法 | |
CN111679042A (zh) | 一种林蛙油冻干粉抗疲劳药理作用的研究方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING RIVALCINE BIOENGINEERING TECHNOLOGY CO., Free format text: FORMER OWNER: LAIFUSAIYIN SCIENCE AND TECHNOLOGY DEVELOPMENT CO LTD, BEIJING Effective date: 20020620 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20020620 Address after: 100873, 3 Whitehead Road, Beijing, Haidian District (Friendship Hotel room 290) Applicant after: Beijing life science biotech. Ltd. Address before: 100873, 3 Whitehead Road, Beijing, Haidian District (Friendship Hotel room 290) Applicant before: Laifusaiyin Science and Technology Development Co Ltd, Beijing |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20020320 Assignee: Laifusaiyin Science and Technology Development Co Ltd, Beijing Assignor: Beijing life science biotech. Ltd. Contract record no.: 2012990000695 Denomination of invention: Nutritive health-care food for supplementing nucleic acid and its preparing process Granted publication date: 20050713 License type: Common License Record date: 20120921 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050713 Termination date: 20190830 |